Table 4 Changes in glucose profile during the study period(n = 66)
From: Use of continuous glucose monitoring in insulin-treated older adults with type 2 diabetes
Baseline | Endpoint | β* | 95%CI | p | |||
|---|---|---|---|---|---|---|---|
Dependent variable | Mean | SD | Mean | SD | |||
TBR (< 70 mg/dL) (%) | 5.81 | 7.05 | 3.82 | 4.72 | -1.00 | -1.75; -0.26 | 0.008 |
TBR 1 (54–70 mg/dL) (%) | 4.06 | 4.00 | 2.92 | 3.44 | -0.57 | -1.01; -0.13 | 0.012 |
TBR 2 (< 54 mg/dL) (%) | 1.76 | 3.46 | 0.89 | 1.77 | -0.43 | -0.83; -0.03 | 0.035 |
TIR (70–180 mg/dL) (%) | 63.51 | 18.92 | 65.51 | 18.81 | 1.00 | -0.49; 2.49 | 0.190 |
TAR (> 180–250 mg/dl) (%) | 30.66 | 20.21 | 30.66 | 19.50 | -0.05 | -0.86; 0.76 | 0.898 |
TAR (> 250 mg/dl) (%) | 8.44 | 12.33 | 8.33 | 12.46 | 0.05 | -0.97; 1.07 | 0.919 |
GV (%) | 34.95 | 7.20 | 32.97 | 6.80 | -0.99 | -1.53; -0.44 | < 0.001 |
GMI | 7.00 | 0.85 | 7.08 | 0.81 | 0.04 | -0.01; 0.10 | 0.133 |